Isotope-Guided Analytical Strategies for Assessing Metabolic Networks in Cancer

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".

Deadline for manuscript submissions: closed (19 April 2024) | Viewed by 3385

Special Issue Editors


E-Mail Website
Guest Editor
Stable Isotope and Metabolomics Core (SIMC) Facility, Albert Einstein College Of Medicine, New York, NY 10461, USA
Interests: GC/MS; stable isotope; metabolic networks

E-Mail Website
Guest Editor
Department of Nutrition, Case Western Reserve University, Cleveland, OH 44109, USA
Interests: metabolic regulation of organs and cells in health and disease; biochemical, isotopic and metabolomic techniques

E-Mail Website
Guest Editor
Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA
Interests: T cell biology; cancer immunotherapy

E-Mail Website
Guest Editor
The Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, Bronx, NY 10461, USA
Interests: metabolomics; mass spectrometry; metabolites identification; biomarker discovery; stable isotope flux; cancer metabolism; infectious diseases

Special Issue Information

Dear Colleagues,

The reprogramming of the cancer metabolism is central to the process of malignant transformation. A growing repertoire of flux analysis techniques have provided new insights into our understanding of the cancer metabolism in primary and metastatic settings, as well as revealing the complex metabolic interplay between cancer cells and other cell types in the tumor microenvironment. Stable isotope-guided analysis, whether targeted or untargeted, has enabled fundamental discoveries in the cancer metabolism. Hypothesis-driven approaches that interpret targeted metabolite 13C, 15N, 18O or 2H labeling patterns have uncovered key nutrient dependencies in tumor and immune cells, revealed metabolic reprogramming driven by oncogenic mutations, and led to the identification of unique metabolic adaptations that enable the continuity of energy generation, while fostering enhanced biosynthetic pathways. In contrast, unsupervised isotope-tracing metabolomics, especially with ultra-high resolution mass spectrometry systems, can measure metabolome-wide shifts in pathways, which is discovery-based and hypothesis-generating without a defined model. 13C metabolic flux analysis (13C-MFA) leverages measured extracellular uptake and secretion rates, as well as isotopic labeling with an assumed metabolic network model, in order to find the most likely solution of fluxes.13C-MFA can be aided by approaches that integrate the constraint-based modeling of metabolic flux, which itself can be used for flux prediction for cancer mechanisms using genome-scale human metabolic network reconstructions. This issue will cover how advances in stable isotope and computational flux methodologies have yielded new insights into metabolic networks within the tumor niche, and then detail how emerging flux methods at the cutting-edge of isotope flux analysis are being applied to examine compartmental and spatial metabolic interactions within tumors.

Dr. Irwin J. Kurland
Prof. Dr. Henri Brunengraber
Dr. Alison E. Ringel
Dr. Yunping Qiu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • spatially resolved metabolism
  • metastatic flux adaptations
  • deconvoluting tumor metabolic heterogeneity
  • flux characterization of immunometabolism
  • constraint-based flux modeling
  • mass isotopomer distribution analysis
  • ultra-high resolution flux characterization
  • in vivo flux quantification
  • system biology integration with flux analyses

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

39 pages, 1836 KiB  
Review
Challenges of Spatially Resolved Metabolism in Cancer Research
by Andrew N. Lane, Richard M. Higashi and Teresa W-M. Fan
Metabolites 2024, 14(7), 383; https://doi.org/10.3390/metabo14070383 - 11 Jul 2024
Viewed by 1179
Abstract
Stable isotope-resolved metabolomics comprises a critical set of technologies that can be applied to a wide variety of systems, from isolated cells to whole organisms, to define metabolic pathway usage and responses to perturbations such as drugs or mutations, as well as providing [...] Read more.
Stable isotope-resolved metabolomics comprises a critical set of technologies that can be applied to a wide variety of systems, from isolated cells to whole organisms, to define metabolic pathway usage and responses to perturbations such as drugs or mutations, as well as providing the basis for flux analysis. As the diversity of stable isotope-enriched compounds is very high, and with newer approaches to multiplexing, the coverage of metabolism is now very extensive. However, as the complexity of the model increases, including more kinds of interacting cell types and interorgan communication, the analytical complexity also increases. Further, as studies move further into spatially resolved biology, new technical problems have to be overcome owing to the small number of analytes present in the confines of a single cell or cell compartment. Here, we review the overall goals and solutions made possible by stable isotope tracing and their applications to models of increasing complexity. Finally, we discuss progress and outstanding difficulties in high-resolution spatially resolved tracer-based metabolic studies. Full article
Show Figures

Figure 1

24 pages, 1605 KiB  
Review
Stable Isotope Tracing Analysis in Cancer Research: Advancements and Challenges in Identifying Dysregulated Cancer Metabolism and Treatment Strategies
by Dalton Hilovsky, Joshua Hartsell, Jamey D. Young and Xiaojing Liu
Metabolites 2024, 14(6), 318; https://doi.org/10.3390/metabo14060318 - 31 May 2024
Cited by 1 | Viewed by 1641
Abstract
Metabolic reprogramming is a hallmark of cancer, driving the development of therapies targeting cancer metabolism. Stable isotope tracing has emerged as a widely adopted tool for monitoring cancer metabolism both in vitro and in vivo. Advances in instrumentation and the development of new [...] Read more.
Metabolic reprogramming is a hallmark of cancer, driving the development of therapies targeting cancer metabolism. Stable isotope tracing has emerged as a widely adopted tool for monitoring cancer metabolism both in vitro and in vivo. Advances in instrumentation and the development of new tracers, metabolite databases, and data analysis tools have expanded the scope of cancer metabolism studies across these scales. In this review, we explore the latest advancements in metabolic analysis, spanning from experimental design in stable isotope-labeling metabolomics to sophisticated data analysis techniques. We highlight successful applications in cancer research, particularly focusing on ongoing clinical trials utilizing stable isotope tracing to characterize disease progression, treatment responses, and potential mechanisms of resistance to anticancer therapies. Furthermore, we outline key challenges and discuss potential strategies to address them, aiming to enhance our understanding of the biochemical basis of cancer metabolism. Full article
Show Figures

Figure 1

Back to TopTop